Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 29 studies | 33% ± 15% | |
| astrocyte | 18 studies | 35% ± 15% | |
| oligodendrocyte | 16 studies | 54% ± 19% | |
| oligodendrocyte precursor cell | 16 studies | 82% ± 11% | |
| pericyte | 16 studies | 27% ± 14% | |
| fibroblast | 14 studies | 24% ± 8% | |
| smooth muscle cell | 12 studies | 24% ± 8% | |
| ciliated cell | 11 studies | 26% ± 11% | |
| glutamatergic neuron | 11 studies | 36% ± 21% | |
| GABAergic neuron | 9 studies | 42% ± 15% | |
| microglial cell | 9 studies | 30% ± 10% | |
| capillary endothelial cell | 8 studies | 22% ± 8% | |
| endothelial cell of lymphatic vessel | 8 studies | 36% ± 11% | |
| macrophage | 7 studies | 28% ± 11% | |
| epithelial cell | 7 studies | 38% ± 20% | |
| interneuron | 7 studies | 41% ± 19% | |
| basal cell | 7 studies | 30% ± 15% | |
| type I pneumocyte | 7 studies | 31% ± 10% | |
| neuron | 5 studies | 42% ± 17% | |
| cardiac muscle cell | 5 studies | 41% ± 9% | |
| club cell | 5 studies | 27% ± 10% | |
| type II pneumocyte | 5 studies | 27% ± 7% | |
| retinal bipolar neuron | 4 studies | 19% ± 2% | |
| granule cell | 4 studies | 37% ± 7% | |
| amacrine cell | 4 studies | 18% ± 2% | |
| Mueller cell | 4 studies | 18% ± 2% | |
| retinal rod cell | 4 studies | 20% ± 4% | |
| endothelial cell of vascular tree | 4 studies | 31% ± 14% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 63% ± 10% | |
| GABAergic interneuron | 3 studies | 32% ± 12% | |
| glial cell | 3 studies | 26% ± 12% | |
| plasma cell | 3 studies | 25% ± 7% | |
| adipocyte | 3 studies | 20% ± 5% | |
| mesothelial cell | 3 studies | 28% ± 8% | |
| GABAergic amacrine cell | 3 studies | 23% ± 3% | |
| OFF-bipolar cell | 3 studies | 17% ± 1% | |
| ON-bipolar cell | 3 studies | 18% ± 1% | |
| glycinergic amacrine cell | 3 studies | 19% ± 1% | |
| rod bipolar cell | 3 studies | 21% ± 2% | |
| connective tissue cell | 3 studies | 20% ± 5% | |
| ependymal cell | 3 studies | 41% ± 12% | |
| myofibroblast cell | 3 studies | 30% ± 7% | |
| goblet cell | 3 studies | 45% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3021.46 | 1444 / 1445 | 99% | 11.99 | 182 / 183 |
| brain | 100% | 4308.53 | 2641 / 2642 | 99% | 34.73 | 700 / 705 |
| lung | 99% | 2112.08 | 575 / 578 | 97% | 8.21 | 1123 / 1155 |
| breast | 100% | 2032.09 | 459 / 459 | 95% | 9.33 | 1060 / 1118 |
| ovary | 100% | 2335.79 | 180 / 180 | 95% | 7.96 | 407 / 430 |
| intestine | 100% | 2420.10 | 965 / 966 | 93% | 4.99 | 489 / 527 |
| prostate | 100% | 2663.93 | 245 / 245 | 92% | 8.86 | 463 / 502 |
| skin | 100% | 4349.23 | 1808 / 1809 | 88% | 6.38 | 417 / 472 |
| stomach | 95% | 1478.68 | 341 / 359 | 93% | 5.73 | 266 / 286 |
| bladder | 100% | 3055.62 | 21 / 21 | 88% | 6.17 | 441 / 504 |
| uterus | 100% | 3609.03 | 170 / 170 | 87% | 8.82 | 399 / 459 |
| thymus | 100% | 2075.10 | 650 / 653 | 86% | 6.77 | 522 / 605 |
| kidney | 100% | 1545.55 | 89 / 89 | 85% | 5.87 | 770 / 901 |
| pancreas | 90% | 842.38 | 295 / 328 | 93% | 5.57 | 165 / 178 |
| adrenal gland | 100% | 1195.21 | 257 / 258 | 73% | 5.02 | 167 / 230 |
| spleen | 100% | 1348.19 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2384.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2223.15 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 2439.70 | 853 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 1232.02 | 788 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 9.81 | 41 / 45 |
| liver | 45% | 295.61 | 102 / 226 | 35% | 1.41 | 143 / 406 |
| eye | 0% | 0 | 0 / 0 | 74% | 2.74 | 59 / 80 |
| peripheral blood | 15% | 115.09 | 138 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.49 | 3 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045747 | Biological process | positive regulation of Notch signaling pathway |
| GO_0030948 | Biological process | negative regulation of vascular endothelial growth factor receptor signaling pathway |
| GO_0006897 | Biological process | endocytosis |
| GO_1903671 | Biological process | negative regulation of sprouting angiogenesis |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0030125 | Cellular component | clathrin vesicle coat |
| GO_0005768 | Cellular component | endosome |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030276 | Molecular function | clathrin binding |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0005543 | Molecular function | phospholipid binding |
| Gene name | EPN2 |
| Protein name | EPN2 protein Epsin 2 Epsin-2 (EPS-15-interacting protein 2) |
| Synonyms | KIAA1065 |
| Description | FUNCTION: Plays a role in the formation of clathrin-coated invaginations and endocytosis. . |
| Accessions | E9PBC1 ENST00000577195.5 Q6NSL9 ENST00000395628.6 J3KSF8 ENST00000347697.6 [O95208-2] J3QKL8 ENST00000571254.1 ENST00000395626.5 ENST00000584633.1 ENST00000314728.10 [O95208-1] ENST00000395620.6 [O95208-2] I3L356 ENST00000584150.5 ENST00000581024.5 J3KTF6 ENST00000580579.5 J3QLN2 J3KSC7 ENST00000577692.5 J3QQJ8 I3L2B2 I3L2H1 ENST00000582015.5 O95208 F6PQP6 J3KSR0 ENST00000583197.5 ENST00000395618.7 [O95208-5] J3KSA6 ENST00000575595.5 ENST00000494192.6 |